IP Library Granted Patent US 8,658,389
Granted Patent B2
US 8,658,389 · App. 12/381,638 · Granted Feb 25, 2014

Antibody conjugates

Inventors: Christopher Bieniarz (Tucson, AZ); Jennifer Wong (Sparks, NV); Mark Lefever (Oro Valley, AZ); Jerome W. Kosmeder, II (Tucson, AZ); Julia Ashworth-Sharpe (Tucson, AZ); Casey A. Kernag (Tucson, AZ)
Assignee: Ventana Medical Systems, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,658,389
App. No.
12/381,638
Granted
Feb 25, 2014
Kind
B2
Abstract

Antibody/signal-generating moiety conjugates are disclosed that include an antibody covalently linked to a signal-generating moiety through a heterobifunctional polyalkyleneglycol linker. The disclosed conjugates show exceptional signal-generation in immunohistochemical and in situ hybridization assays on tissue sections and cytology samples. In one embodiment, enzyme-metallographic detection of nucleic acid sequences with hapten-labeled probes can be accomplished using the disclosed conjugates as a primary antibody without amplification.

Claims (20)

1. A method for detecting a molecule of interest in a tissue section or a cytology sample, comprising:

contacting the tissue section or cytology sample with an antibody-polyethylene glycol (PEG) linker-signal-generating moiety conjugate comprising an antibody covalently linked to at least 3 signal-generating moieties, wherein each signal-generating moiety is linked to the antibody through a monodisperse,

heterobifunctional PEG linker to provide an antibody-PEG linker-signal-generating moiety conjugate having the formula

wherein Ab is an antibody, SM is an enzyme signal-generating moiety, n=4 to 12 and s=3 to 10; and

detecting a signal generated by the antibody-PEG linker-signal-generating moiety conjugate that indicates the presence of the molecule of interest in the sample.

2. The method of claim 1 , wherein the enzymes are horseradish peroxidase or alkaline phosphatase.

3. The method of claim 1 , further comprising contacting the tissue section or cytology sample with a water-soluble metal ion and a redox-inactive substrate of the enzymes that is converted to a redox-active agent by the enzymes, which redox-active agent reduces the metal ion causing it to precipitate.

4. The method of claim 3 , wherein the enzymes are alkaline phosphatase.

5. The method of claim 1 , wherein the signal-generating moieties are oxido-reductase enzymes and the method further comprises contacting the tissue section or cytology sample with a water soluble metal ion, an oxidizing agent and a reducing agent.

6. The method of claim 5 , wherein the oxido-reductase enzymes are horseradish peroxidase.

7. The method of claim 1 , wherein the antibody comprises an anti-antibody antibody.

8. The method of claim 1 , wherein the antibody comprises an anti-hapten antibody, and the method further comprises contacting the tissue section or cytology sample with a hapten-labeled antibody or a hapten-labeled nucleic acid sequence.

9. The method of claim 1 , further comprising contacting the tissue section or cytology sample with a chromogenic, fluorogenic and/or luminogenic compound.

10. The method of claim 1 , wherein s=3 to 6.

11. The method of claim 10 , wherein s=3 to 4.

12. The method of claim 11 , wherein SM is horseradish peroxidase or alkaline phosphatase.

13. A method for detecting a molecule of interest in a tissue section, comprising: contacting the tissue section with an antibody-PEG linker-signal-generating moiety conjugate having the formula:

wherein Ab is an antibody, SM is a signal-generating moiety selected from alkaline phosphatase or horseradish peroxidase, n=4 to 12 and s=3 to 6, and wherein the PEG linker that linked the signal-generating moiety SM to the antibody Ab in the antibody-PEG linker-signal-generating moiety conjugate is a monodispersed PEG linker;

contacting the conjugate with a chromogenic substrate of alkaline phosphatase or horseradish peroxidase; and,

detecting a chromogen generated by the antibody-PEG linker-signal-generating moiety conjugate from the chromogenic substrate that indicates the presence of the molecule of interest in the sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2009
From: BIENIARZ, CHRISTOPHER; WONG, JENNIFER; LEFEVER, MARK; KOSMEDER, JEROME W.; ASHWORTH-SHARPE, JULIA; KERNAG, CASEY A.
To: VENTANA MEDICAL SYSTEMS, INC.
Reel/Frame 022500/0808 →
Continuity (3)
Division 11413418 · Apr 27, 2006
Provisional Application 60675759 · Apr 28, 2005
Related Publication 20090176253A1 · Jul 9, 2009